BackViridian Therapeutics Overview

Viridian Therapeutics Operating Income

Operating Income for VRDN.

Quarterly Operating Income

$-116169000.00
↑ 23.76% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-385698000.00
↑ 14.45% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin